MB "Inovacinis rytojus" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 178,504 |
| 99,723 |
| 56,049 |
| 53,206 |
| 29,724 |
| 98.58 |
| 29.81 |
| 42,951 |
| 10,739 |
| 9,029 |
| 51,657 |
| 2024 |
|---|
| 33,129 |
| 33,129 |
| -1,076 |
| -1,160 |
| -1,160 |
| 100.00 |
| -3.50 |
| 21,959 |
| 21,714 |
| 938 |
| 42,735 |
| 2025 |
|---|
| 20,915 |
| - |
| -5,765 |
| -5,765 |
| - |
| 100.00 |
| -27.56 |
| 16,149 |
| 8,109 |
| 52 |
| 24,206 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 20,915 |
| - |
| -5,765 |
| -5,765 |
| - |
| 100.00 |
| -27.56 |
| 16,149 |
| 8,109 |
| 52 |
| 24,206 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
20,915 €-37 % *
Sales per employee (€)
-Profit before tax (€)
-5,765 €-436 % *
Net Profit (€)
-5,765 €-397 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-27.56 %-687.43 % *
Equity (€)
16,149 €-26 % *
Amounts Payable And Liabilities (€)
8,109 €-63 % *
Non-current Assets (€)
52 €-94 % *
CurrentAssets (€)
24,206 €-43 % *
